Environmental & Immune Health Conditions We Treat

Environmental medicine sits at the edge of what conventional care is designed to investigate. A standard panel of blood work checks organ function, inflammatory markers, and common pathogens — but it is not built to detect mycotoxin accumulation, identify HLA-DR genetic susceptibility to biotoxin illness, or uncover the low-grade viral or bacterial infections that persist in immune-compromised tissue for years. Patients with these conditions cycle through specialists, receive normal results, and are frequently told that nothing is wrong.

Florida’s climate — subtropical humidity, frequent flooding, aging building stock, and year-round pollen seasons — creates a particularly high-exposure environment for all three of the conditions covered on this page. Mold grows aggressively in water-damaged structures throughout the state. Tick-borne illness is endemic and expanding in range. Allergy seasons here have no true off-season. Functional medicine addresses all three with specific testing protocols and individualized treatment designed for each patient’s biology and exposure history.

Approximately 25% of the population carries HLA-DR genetic variants that prevent the immune system from tagging biotoxins for elimination. In these individuals, exposure to a water-damaged building — defined by the presence of mold, mycotoxins, bacteria, actinomycetes, and volatile organic compounds, not just visible mold growth — initiates a biotoxin accumulation cascade. The toxins recirculate through the body via bile reabsorption, attaching to cell membranes, impairing mitochondrial function, dysregulating inflammatory cytokines, and degrading regulatory neuropeptides over time.

The symptom constellation of CIRS is notoriously broad and is frequently misattributed to other diagnoses: fatigue, cognitive impairment and memory loss, headaches, joint pain, muscle aches, unusual thirst, increased urination, light sensitivity, word retrieval problems, shortness of breath, and mood disturbance are all among the documented presentations. A 2024 peer-reviewed review in Annals of Medicine and Surgery confirmed CIRS as a progressive, diagnosable, and treatable condition with objective laboratory abnormalities including elevated TGF-beta1, C4a, and MMP-9, and depressed MSH and VIP levels.

Diagnosis requires a multi-step process: exposure history and symptom cluster analysis, HLA-DR genetic testing, Visual Contrast Sensitivity (VCS) screening, and a specific biomarker panel that goes far beyond standard inflammatory markers. Treatment follows a validated sequential protocol: removing the patient from biotoxin exposure first, then binding agents to reduce recirculating toxin load, followed by targeted interventions to restore the regulatory neuropeptides and downstream hormonal and immune systems that CIRS disrupts. Florida’s climate and building environment make CIRS evaluation a meaningful part of our environmental medicine practice.

The CDC estimates approximately 476,000 Americans are diagnosed with Lyme disease annually — and the true incidence is believed to be substantially higher, as surveillance-based counting misses a significant proportion of cases. Surveys of patients with chronic illness find that roughly 50% of those with Lyme disease also carry at least one tick-borne co-infection — most commonly Bartonella, Babesia, or Anaplasma — each requiring different diagnostic approaches and treatment considerations than Borrelia alone.

The challenge with chronic stealth infections is not primarily treatment — it is detection. Standard Lyme serology (ELISA and Western blot) has well-documented sensitivity limitations, particularly in the chronic phase, where immune dysregulation may suppress the antibody response that these tests depend on. Intracellular pathogens like Bartonella frequently produce false negatives on standard panels. Viral reactivation — EBV, CMV, and HHV-6 are latent in most adults and can reactivate under immune stress to produce ongoing symptoms — is evaluated through specific antibody titers (IgG, IgM, IgA patterns) and viral load testing that is rarely ordered in standard care.

Our evaluation of suspected chronic stealth infections uses advanced tick-borne panels (IGeneX, Galaxy Diagnostics, or Vibrant Wellness depending on the clinical picture), comprehensive viral reactivation panels, Mycoplasma and Chlamydia pneumoniae serology, NK cell activity and immune function assessment, and inflammatory cytokine profiling. Treatment is individualized by pathogen and patient biology — combining antimicrobial protocols (herbal, pharmaceutical, or both) with immune-modulating, mitochondrial-supporting, and biofilm-disrupting strategies as the clinical picture warrants.

According to a January 2026 CDC NCHS Data Brief using 2024 National Health Interview Survey data, 31.7% of US adults — nearly 1 in 3 — have at least one diagnosed allergic condition. Seasonal allergies affect 25.2% of adults, with over 82 million Americans diagnosed with allergic rhinitis. These numbers have increased steadily over recent decades, driven by climate-related extension of pollen seasons, increasing indoor air pollutant load, antibiotic-disrupted microbiome development, and declining microbial diversity in modern living environments.

Conventional allergy management centers on antihistamines, nasal corticosteroids, and immunotherapy (allergy shots or sublingual drops). These are often helpful for symptomatic relief and desensitization. What they do not address is the immune terrain that makes the allergic response so exaggerated in the first place. Increased intestinal permeability (leaky gut) allows antigens into systemic circulation that drive systemic immune sensitization. Gut dysbiosis reduces regulatory T-cell activity and shifts the immune system toward Th2 dominance — the allergic response pattern. Vitamin D deficiency impairs immune tolerance mechanisms. Mold co-exposure, which is especially common in Florida, amplifies both the mast cell and IgE-driven allergic response.

Functional medicine evaluation of environmental allergies investigates the immune terrain: gut microbiome and intestinal permeability, vitamin D status, inflammatory markers, food sensitivity panel (which frequently overlaps with and amplifies environmental allergic load), mold and mycotoxin exposure history, and where relevant, comprehensive allergy panels including IgE and IgG testing for environmental and food antigens. Treatment addresses the underlying immune dysregulation alongside or ahead of symptomatic management — building immune tolerance rather than indefinitely suppressing the allergic response. Environmental exposures frequently show up alongside fatigue and widespread aches, which is why we also look at chronic pain and energy disorders when building a care plan.

Florida’s environment creates a uniquely high-exposure context for all three conditions on this page. The subtropical climate — high humidity, warm temperatures year-round, and frequent flooding events — accelerates mold growth in residential and commercial buildings. Unlike northern states where mold seasonality is limited, water-damaged Florida structures support aggressive mold colonization year-round, and mycotoxin levels in affected buildings can be substantially elevated.

Tick-borne illness, once associated primarily with the Northeast, has expanded significantly southward. Lone Star tick, Gulf Coast tick, and black-legged tick populations are well established throughout Florida, carrying Borrelia, Ehrlichia, Rickettsia, and Bartonella species. The CDC’s surveillance data continues to show increasing case counts across the South. Meanwhile, Florida’s year-round pollen season — oak, pine, grass, and mold spores cycling through the calendar without interruption — means the total annual allergen exposure load for Florida residents is among the highest in the country.

Our practice is built for this environment. We are familiar with the specific mold species common to Florida buildings, the tick-borne pathogen profile relevant to this region, and the immune dysregulation patterns produced by sustained high-allergen and high-biotoxin exposure. When patients from across Florida come to us with symptoms that other practices have not been able to explain, the environmental history is often where answers begin.